Explore

August AI Launches U.S. Telehealth Services with Free Global Chatbot

August AI Launches U.S. Telehealth Services with Free Global Chatbot

August AI, an artificial intelligence-enabled telehealth provider, has officially launched its direct-to-consumer telehealth services in the U.S. The company offers 'August Care,' a monthly membership for $39, which includes clinical services, discounted lab tests, and quick prescription fulfillment. While its telehealth services are U.S.-specific, August AI continues to provide its AI chatbot globally for free, offering information based on its knowledge base and guidelines, but not medical advice. The company was founded in 2022 by Anuruddh Mishra, who aimed to address gaps in healthcare access and knowledge after his own challenging experience with misdiagnosis. August AI's global chatbot is currently used by over 9 million people across 160 countries and is available in more than 30 languages. The AI model is built with clinical input to ensure safety and can flag risks, escalating to appropriate care when necessary. Licensed physicians oversee all clinical decisions within August Care.

Oracle Health Expands AI Agent to Nurses for Enhanced Clinical Documentation and Chart Navigation

Oracle Health Expands AI Agent to Nurses for Enhanced Clinical Documentation and Chart Navigation

Oracle Health has made its Oracle Health Clinical AI Agent, previously utilized by physicians across the U.S., available to nurses. This expansion aims to alleviate the administrative burden on nurses by providing automated tools for chart navigation and real-time documentation. Nurses often spend significant time on tasks such as searching patient records and documenting care, which can detract from direct patient interaction and lead to after-shift charting. The AI agent is designed to integrate seamlessly into existing nursing workflows. For instance, it speeds up chart navigation by allowing nurses to locate patient records using natural language voice commands, eliminating the need for manual searches. After accessing a patient chart, nurses can use the agent’s AI-powered summaries to quickly grasp a patient’s current condition and other relevant information without a full chart review. Additionally, the agent offers voice-enabled discrete charting, enabling nurses to dictate information like weight, ...

Zocdoc Expands Healthcare Access with Digital Marketplace for Patient-Provider Connections

Zocdoc Expands Healthcare Access with Digital Marketplace for Patient-Provider Connections

Zocdoc, a leading digital health marketplace, is actively working to enhance patient access to healthcare services. The company's platform allows millions of users each month to find and book appointments with in-network healthcare providers, including dermatologists and mental health nurse practitioners, for both in-person and video visits. Patients can compare providers based on verified reviews, book instantly, and manage appointments online. Founded in 2007, Zocdoc's mission is to empower patients by simplifying the process of finding and scheduling medical care. The company emphasizes diversity and inclusion in its team, aiming to reflect the diverse patient and provider communities it serves. Zocdoc also supports providers by helping them reach new patients, fill last-minute openings, and improve the overall healthcare experience.

U.S. Representative Erin Houchin Tours Ossium Health's Indianapolis Facility, Highlighting Biotechnology Advancements

U.S. Representative Erin Houchin Tours Ossium Health's Indianapolis Facility, Highlighting Biotechnology Advancements

U.S. Representative Erin Houchin recently visited Ossium Health's Indianapolis production facility. During her visit, she observed the manufacturing operations of the world's first bone marrow bank, which sources bone marrow from deceased organ donors. Representative Houchin commended Ossium Health for its life-saving work and its significant contribution to Indiana's biotechnology sector. She toured the production and laboratory spaces and engaged with the company's leadership and scientific team to understand their efforts in improving treatment outcomes for patients suffering from life-threatening blood and immune diseases. To date, 29 patients have received transplants using Ossium's organ donor-derived bone marrow, with four of these patients located in Indiana. Kevin Caldwell, Ossium's CEO, Co-Founder & President, emphasized the importance of legislative leaders witnessing their work firsthand, as each graft released from the facility provides a life-saving option for patients.

AABIP Establishes Advanced Practice Providers Allied Health Chapter to Enhance Interventional Pulmonology Care

AABIP Establishes Advanced Practice Providers Allied Health Chapter to Enhance Interventional Pulmonology Care

The American Association for Bronchology and Interventional Pulmonology (AABIP) has established an Advanced Practice Providers (APP) & Allied Health Chapter. This new chapter aims to support and integrate professionals such as Advanced Practice Providers, Registered Nurses, and Respiratory Therapists who work within Interventional Pulmonology and Advanced Bronchoscopy practices. The chapter provides its members with continuous access to resources including an APP Tool Kit, an APP Enrichment Series, networking opportunities, resource sharing, mentorship, and professional growth and development opportunities. Members also gain access to the Journal of Bronchology and Interventional Pulmonology (JOBIP). The chapter holds quarterly meetings and organizes various activities, including Journal Clubs and Respiratory Therapist Coalition Meetings, to foster collaboration and education among allied health professionals in the field.

US FDA advisers endorse Grail cancer test's benefits in key vote

US FDA advisers endorse Grail cancer test's benefits in key vote

By Padmanabhan Ananthan and Kamal Choudhury Sept 23 (Reuters) - A panel of outside experts advising the US FDA said on Wednesday the benefits of Grail's blood-based cancer detection test outweigh its risks, paving the way for a potential landmark approval in cancer screening.

Anthropic and OpenEvidence Partner to Provide Free Medical AI to Doctors in Developing Nations

Anthropic and OpenEvidence Partner to Provide Free Medical AI to Doctors in Developing Nations

Anthropic and OpenEvidence are collaborating to offer a specialized, free version of OpenEvidence's medical AI platform to doctors in approximately 100 low- and middle-income countries. OpenEvidence, an AI tool currently used by American and European clinicians to answer clinical questions using peer-reviewed research and treatment guidelines, is adapting its system for the unique healthcare needs of each region. Anthropic provides the backend technology for this initiative. The project aims to address healthcare disparities by providing access to medical literature and diagnostic support in areas where resources are limited. OpenEvidence founder Daniel Nadler stated that U.S. clinicians used the platform 42 million times in August. The company has been working with health organizations in Rwanda and Botswana to modify its tools to account for different disease patterns, diagnostic resources, and available treatments compared to wealthier nations. The project in Rwanda involved 45 local doctors and nurses ...

University of Pennsylvania Symposium Highlights Workplace Improvements as Key to Addressing Global Nursing Shortage

University of Pennsylvania Symposium Highlights Workplace Improvements as Key to Addressing Global Nursing Shortage

A recent symposium at the University of Pennsylvania, led by Linda Aiken and Matthew McHugh of the Penn School of Nursing, emphasized that the global nursing shortage requires more than just educating and recruiting additional nurses. Healthcare leaders at the event stressed the necessity of improving working conditions to retain existing nurses and other clinicians who are experiencing burnout and leaving the profession. The symposium highlighted encouraging results from Magnet4Europe, an initiative that paired 65 European hospitals with 65 Magnet-designated U.S. hospitals. This program aimed to help European hospitals adopt evidence-based nursing practices and organizational changes modeled on the Magnet framework, which emphasizes strong nursing leadership, frontline participation in decision-making, evidence-based practice, and professional development. After four years, participating European hospitals showed significant improvements in burnout rates, clinician retention, safety, and quality of care.

CooperSurgical Initiates Class I Recall of INCA Infant Nasal CPAP Sets Due to Disconnection Risk

CooperSurgical Initiates Class I Recall of INCA Infant Nasal CPAP Sets Due to Disconnection Risk

The FDA has classified CooperSurgical's removal of specific lots of INCA Infant Nasal CPAP Sets as a Class I recall, the most serious type, indicating that continued use of the device may cause serious injury or death. The recall affects several part numbers and lot codes of the INCA Infant Nasal CPAP Complete Set and Replacement Set. The issue stems from a potential loose connection between the flexible tubing and the nasal cannula, which can occur during assembly or while in use. If this loose connection is not detected, it can lead to a loss of CPAP pressure, reducing treatment effectiveness and potentially causing decreased oxygenation in infant patients. CooperSurgical has issued a letter to affected customers, recommending that they cease use and distribution of the affected products and return them. As of August 11, CooperSurgical has not reported any serious injuries or deaths associated with this issue.

Connecticut Department of Developmental Services Cited for Non-Compliance in Health and Safety Requirements

Connecticut Department of Developmental Services Cited for Non-Compliance in Health and Safety Requirements

The Office of Inspector General (OIG) has identified significant non-compliance issues within the Connecticut Department of Developmental Services (DDS) and its providers regarding federal waiver and state health and safety requirements for individualized home support services. An audit conducted by the OIG revealed that Connecticut failed to properly follow the provider certification process in 32 instances out of 81 reviewed providers. Additionally, individual plans were not reviewed annually in 6 out of 124 cases, and critical incidents were improperly reported and recorded in 70 instances. Site visits further exposed that providers did not complete required criminal background checks (23 instances) and abuse and neglect registry checks (29 instances), nor did they ensure mandatory training was completed within specified timeframes (106 instances). These findings indicate systemic failures in oversight and adherence to established protocols designed to protect Medicaid enrollees with intellectual and de...

Virtual Healthcare Market Projected for Significant Growth with 12.9% CAGR by 2033

Virtual Healthcare Market Projected for Significant Growth with 12.9% CAGR by 2033

The virtual healthcare market is experiencing rapid expansion, driven by increasing consumer demand for convenient and cost-efficient care. Projections indicate a compound annual growth rate (CAGR) of 12.9% from 2026 to 2033. This growth is fueled by the integration of wearable health technology, the rise of virtual-first health plans, and the stabilization of reimbursement parity with in-person visits. Key players like Teladoc Health, American Well (Amwell), and MDLIVE are leading this sector by offering comprehensive platforms that include teleconsultations, remote patient monitoring, and integrated mental health services. Advancements in 5G connectivity, edge computing, and generative AI are enhancing diagnostic accuracy and platform interoperability, further supporting this market expansion. While the FDA’s digital health precertification program is accelerating software approvals, the upcoming expiration of COVID-era telehealth waivers in the U.S. introduces some reimbursement uncertainty. Despite the...

Breakthrough T1D and Medical Organizations Establish Global Type 1 Diabetes Screening Schedule for Children

Breakthrough T1D and Medical Organizations Establish Global Type 1 Diabetes Screening Schedule for Children

Breakthrough T1D, in collaboration with 20 major diabetes and medical organizations worldwide, has established a new clinical framework for integrating general population screening for Type 1 Diabetes (T1D) into routine pediatric healthcare. Published in Diabetologia, the official journal of the European Association for the Study of Diabetes (EASD), this International Consensus Guidance outlines a simple blood test to detect islet autoantibodies in the early stages of T1D. The recommended screening schedule involves three age windows: the first screen between ages 2 and 4, a second screen between ages 6 and 8 if the first is negative, and a final routine screen between ages 10 and 15. A 'catch-up' screening is also recommended for children not previously tested, and a one-time screening after age 15 is advised for adolescents and adults. This initiative aims to identify T1D before symptoms appear, allowing for proactive treatment and management.